New Sandoz Board of Directors appointed Novartis Board of Directors approves the recommendation of Sandoz Chairman-designate for the future Sandoz Board of Directors, to start preparatory work in June, followed by formal constitution in H2...

Science Crossing Borders: Celebrating the Contributions of Immigrant Scientists NEW YORK, Oct. 05, 2022 (GLOBE NEWSWIRE) -- They come from around the world—born in Taiwan, India, Lebanon, Israel, Romania, and Russia, among other places—but they all call the United States home....

Novartis appoints Fiona Marshall, Ph.D., President of the Novartis Institutes for BioMedical Research as Jay Bradner, M.D., steps down from the Executive Committee of Novartis After seven years as President of NIBR and a member of the ECN, Dr. Bradner will pursue a next chapter of scientific contribution and leadership outside of NovartisBuilding on NIBR foundation, Dr....

SEngine Precision Medicine Names Surgical Oncologist and Cancer Care Advocate Dr. Astrid Margossian as Chief Medical Officer SEATTLE, Washington, Nov. 14, 2019 (GLOBE NEWSWIRE) -- SEngine Precision Medicine, an oncology pioneer accelerating cancer drug discovery through its proprietary diagnostic platform known as The...